Skip to main content
SpringerLink
Log in

Épidémiologie, registres, dépistage

  • Chapter
Les cancers digestifs

Part of the book series: Oncologie Pratique ((ONCOLPRAT))

  • 320 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Faivre J (2003) Fréquence et pronostic des cancers digestifs: tendances. 21e Journées nationales de formation continue en hépato-gastro-entérologie; Paris

    Google Scholar 

  2. Comité national des registres. Rapport d’activité 1996–1999. Paris: Inserm, 2000

    Google Scholar 

  3. Remontet L, Esteve J, Bouvier AM et al. (2003) Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 51: 3–30

    CAS  PubMed  Google Scholar 

  4. Msika S, Benhamiche AM, Tazi MA et al. (2000) Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg 24: 1137–42

    Article  CAS  PubMed  Google Scholar 

  5. Mitry E, Benhamiche AM, Couillault C et al. (2002) Effect of age, period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population, 1976–1995. Eur J Cancer Prev 11: 529–34

    Article  CAS  PubMed  Google Scholar 

  6. Mitry E, Bouvier AM, Esteve J, Faivre J (2002) Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 89: 1557–62

    Article  CAS  PubMed  Google Scholar 

  7. Finn-Faivre C, Maurel J, Benhamiche AM et al. (1999) Evidence of improving survival of patients with rectal cancer in France: a population-based study. Gut 44: 377–81

    CAS  PubMed  Google Scholar 

  8. Finn-Faivre C, Bouvier AM, Phelip JM et al. (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51: 60–4

    Google Scholar 

  9. Mitry E, Bouvier AM, Estève J, Faivre J (2003) Comment expliquer l’amélioration de la survie des cancers colorectaux? Étude de population (1976–1999). Gastroenterol Clin Biol 27(HS1): A102

    Google Scholar 

  10. Berrino F, Capocaccia R, Estève J et al. (1999) Survival of cancer patients in Europe: the Eurocare 2 study. IARC Scientific Publication no 151, Lyon

    Google Scholar 

  11. Bretagne JF, Faivre J (2000) La Société nationale française de gastro-entérologie recommande la mise en place d’un dépistage généralisé et organisé du cancer colorectal en France. Gastroenterol Clin Biol 24: 492–3

    CAS  PubMed  Google Scholar 

  12. Young GP, St John DJ, Winawer SJ, Rozen P (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97: 2499–507

    PubMed  Google Scholar 

  13. Ransohoff DF, Lang CA (1997) Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 126: 811–22

    CAS  PubMed  Google Scholar 

  14. Launoy G, Smith TC, Duffy SW, Bouvier V (1997) Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 73: 220–4

    Article  CAS  PubMed  Google Scholar 

  15. Jouve JL, Remonte L, Dancourt V et al. (2001) Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening. Br J Cancer 84: 1477–1481

    Article  CAS  PubMed  Google Scholar 

  16. Gyrd-Hansen D, Sogaard J, Kronborg O (1997) Analysis of screening data: colorectal cancer. Int J Epidemiol 26: 1172–81

    Article  CAS  PubMed  Google Scholar 

  17. Bertario L, Spinelli P, Gennari L et al. (1988) Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci 33: 609–13

    Article  CAS  PubMed  Google Scholar 

  18. Macrae FA, St John DJ (1982) Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 82: 891–8

    CAS  PubMed  Google Scholar 

  19. Pignone M, Campbell MK, Carr C, Phillips C (2001) Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 4: 150–6

    CAS  PubMed  Google Scholar 

  20. Selby JV, Friedman GD, Quesenberry CP, Jr, Weiss NS (1993) Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 118: 1–6

    CAS  PubMed  Google Scholar 

  21. Wahrendorf J, Robra BP, Wiebelt H et al. (1993) Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 2: 221–7

    CAS  PubMed  Google Scholar 

  22. Lazovich D, Weiss NS, Stevens NG et al. (1995) A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screening 2: 84–9

    CAS  Google Scholar 

  23. Zappa M, Castiglione G, Grazzini G et al. (1997) Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 73: 208–10

    Article  CAS  PubMed  Google Scholar 

  24. Faivre J, Tazi MA, El Mrini T et al. (1999) Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 79: 680–3

    Article  CAS  PubMed  Google Scholar 

  25. Saito H, Soma Y, Koeda J et al. (1995) Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 61: 465–9

    CAS  PubMed  Google Scholar 

  26. Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91: 434–7

    Article  CAS  PubMed  Google Scholar 

  27. Mandel JS, Church TR, Bond JH et al. (2000) The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer. N Engl J Med 343: 1603–7

    CAS  PubMed  Google Scholar 

  28. Kewenter J, Bjork S, Haglind E et al. (1988) Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 62: 645–51

    CAS  PubMed  Google Scholar 

  29. Hardcastle JD, Chamberlain JO, Robinson MEH et al. (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472–77

    Article  CAS  PubMed  Google Scholar 

  30. Kronborg O, Fenger C, Olsen J et al. (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467–71

    Article  CAS  PubMed  Google Scholar 

  31. Faivre J, Dancourt V, Lejeune C et al. (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126: 1674–80

    Article  PubMed  Google Scholar 

  32. Towler BP, Irwig L, Glasziou P et al. (2003) Screening for colorectal cancer using the faecal occult blood test, hemoccult (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update software

    Google Scholar 

  33. Towler B, Irwig L, Glasziou P et al. (1998) A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. Br Med J 317: 559–65

    CAS  Google Scholar 

  34. Anderson WF, Guyton KZ, Hiatt RA et al. (2002) Colorectal cancer screening for persons at average risk. J Natl Cancer Inst 94: 1126–33

    PubMed  Google Scholar 

  35. Verne JE, Aubrey R, Love SB et al. (1998) Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. Br Med J 317: 182–5

    CAS  Google Scholar 

  36. ANAES (2001) Place de la coloscopie virtuelle dans le dépistage du cancer colorectal. Paris

    Google Scholar 

  37. Traverso G, Shuber A, Levin B et al. (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346: 311–20

    Article  CAS  PubMed  Google Scholar 

  38. Traverso G, Shuber A, Olsson L et al. (2002) Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 359: 403–4

    Article  CAS  PubMed  Google Scholar 

  39. Laurent-Puig P (1997) Survival and acquired genetic alterations in colorectal cancer. Gastroenterol Clin Biol 21: 751–3

    CAS  PubMed  Google Scholar 

  40. Winawer S, Fletcher R, Rex D et al. (2003) Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124: 544–60

    Article  PubMed  Google Scholar 

  41. Atkin W, Martin JP (2001) Stool DNA-based colorectal cancer detection: Finding the needle in the Haystack. J Natl Cancer Inst 93: 798–9

    Article  CAS  PubMed  Google Scholar 

  42. Faivre J, Dancourt V (2002) Le dépistage du cancer colorectal. Certitudes et questions. Gastroenterol Clin Biol 26: B86–93

    PubMed  Google Scholar 

  43. (1998) Conférence de consensus-Prévention, dépistage et prise en charge des cancers du côlon. Gastroenterol Clin Biol 22: 205–26

    Google Scholar 

  44. Arveux P, Lejeune C, Pitard A (1998) Coûts d’un programme efficient de dépistage du cancer du côlon. Gastroenterol Clin Biol 22: S49–S55

    CAS  PubMed  Google Scholar 

  45. Jorgensen OD, Kronborg O, Fenger C (2002) A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50: 29–32

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. E. Mitry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Mitry, E. (2006). Épidémiologie, registres, dépistage. In: Les cancers digestifs. Oncologie Pratique. Springer, Paris. https://doi.org/10.1007/2-287-30874-1_1

Download citation

  • DOI: https://doi.org/10.1007/2-287-30874-1_1

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22087-6

  • Online ISBN: 978-2-287-30874-1

Publish with us

Policies and ethics

Search

Navigation